Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Affiliations

• ¹ Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany.
• ² University Hospital Leipzig, 04106, Leipzig, Germany.
• ³ Department of Hematology and Oncology, Hospital Magdeburg, Magdeburg, Germany.
• ⁴ Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany.
• ⁵ Department of Hematology and Oncology, University Hospital, Halle, Germany.
• ⁶ Department of Hematology and Oncology, Klinikum Schwerin, Schwerin, Germany.
• ⁷ Departement of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
• ⁸ Medizinische Klinik, Carl-Thieme-Klinikum GmbH, Cottbus, Germany.
• ⁹ Department of Hematology and Oncology, Helios Klinikum Erfurt, Erfurt, Germany.
• ¹⁰ Klinikum Dessau, Dessau, Germany.
• ¹¹ Klinikum, Zittau, Germany.
• ¹² Department of Medicine I, Wilhelminen Cancer Research Institute, WilhelminenhospitalVienna, Austria.
• ¹³ Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany.
• ¹⁴ Department of Hematology, Oncology and Palliative Care, Ernst Von Bergmann Hospital, Potsdam, Germany.
• ¹⁵ Hematology and Oncology, University of Greifswald, Greifswald, Germany.
• ¹⁶ University Hospital Leipzig, 04106, Leipzig, Germany. dietger.niederwieser@medizin.uni-leipzig.de.
• ¹⁷ Lithuanian University of Health Sciences, Kaunas, Lithuania. dietger.niederwieser@medizin.uni-leipzig.de.
• ¹⁸ Aichi Medical University, Nagakute, Japan. dietger.niederwieser@medizin.uni-leipzig.de.